Kaesmacher, Johannes; Cavalcante, Fabiano; Kappelhof, Manon; Treurniet, Kilian M; Rinkel, Leon; Liu, Jianmin; Yan, Bernard; Zi, Wenjie; Kimura, Kazumi; Eker, Omer F; Zhang, Yongwei; Piechowiak, Eike I; van Zwam, Wim; Liu, Sheng; Strbian, Daniel; Uyttenboogaart, Maarten; Dobrocky, Tomas; Miao, Zhongrong; Suzuki, Kentaro; Zhang, Lei; ... (2024). Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-Analysis. JAMA : the journal of the American Medical Association, 331(9), pp. 764-777. American Medical Association 10.1001/jama.2024.0589
Text
jama_kaesmacher_2024_oi_240007_1707161374.63839.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (413kB) |
IMPORTANCE
The benefit of intravenous thrombolysis (IVT) for acute ischemic stroke declines with longer time from symptom onset, but it is not known whether a similar time dependency exists for IVT followed by thrombectomy.
OBJECTIVE
To determine whether the benefit associated with IVT plus thrombectomy vs thrombectomy alone decreases with treatment time from symptom onset.
DESIGN, SETTING, AND PARTICIPANTS
Individual participant data meta-analysis from 6 randomized clinical trials comparing IVT plus thrombectomy vs thrombectomy alone. Enrollment was between January 2017 and July 2021 at 190 sites in 15 countries. All participants were eligible for IVT and thrombectomy and presented directly at thrombectomy-capable stroke centers (n = 2334). For this meta-analysis, only patients with an anterior circulation large-vessel occlusion were included (n = 2313).
EXPOSURE
Interval from stroke symptom onset to expected administration of IVT and treatment with IVT plus thrombectomy vs thrombectomy alone.
MAIN OUTCOMES AND MEASURES
The primary outcome analysis tested whether the association between the allocated treatment (IVT plus thrombectomy vs thrombectomy alone) and disability at 90 days (7-level modified Rankin Scale [mRS] score range, 0 [no symptoms] to 6 [death]; minimal clinically important difference for the rates of mRS scores of 0-2: 1.3%) varied with times from symptom onset to expected administration of IVT.
RESULTS
In 2313 participants (1160 in IVT plus thrombectomy group vs 1153 in thrombectomy alone group; median age, 71 [IQR, 62 to 78] years; 44.3% were female), the median time from symptom onset to expected administration of IVT was 2 hours 28 minutes (IQR, 1 hour 46 minutes to 3 hours 17 minutes). There was a statistically significant interaction between the time from symptom onset to expected administration of IVT and the association of allocated treatment with functional outcomes (ratio of adjusted common odds ratio [OR] per 1-hour delay, 0.84 [95% CI, 0.72 to 0.97], P = .02 for interaction). The benefit of IVT plus thrombectomy decreased with longer times from symptom onset to expected administration of IVT (adjusted common OR for a 1-step mRS score shift toward improvement, 1.49 [95% CI, 1.13 to 1.96] at 1 hour, 1.25 [95% CI, 1.04 to 1.49] at 2 hours, and 1.04 [95% CI, 0.88 to 1.23] at 3 hours). For a mRS score of 0, 1, or 2, the predicted absolute risk difference was 9% (95% CI, 3% to 16%) at 1 hour, 5% (95% CI, 1% to 9%) at 2 hours, and 1% (95% CI, -3% to 5%) at 3 hours. After 2 hours 20 minutes, the benefit associated with IVT plus thrombectomy was not statistically significant and the point estimate crossed the null association at 3 hours 14 minutes.
CONCLUSIONS AND RELEVANCE
In patients presenting at thrombectomy-capable stroke centers, the benefit associated with IVT plus thrombectomy vs thrombectomy alone was time dependent and statistically significant only if the time from symptom onset to expected administration of IVT was short.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology 04 Faculty of Medicine > Pre-clinic Human Medicine > Department of Clinical Research (DCR) 04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic and Interventional Neuroradiology |
UniBE Contributor: |
Kaesmacher, Johannes, Piechowiak, Eike Immo, Dobrocky, Tomas, Meinel, Thomas Raphael, Seiffge, David Julian, Bütikofer, Lukas (B), Fischer, Urs Martin, Gralla, Jan |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1538-3598 |
Publisher: |
American Medical Association |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
08 Feb 2024 13:06 |
Last Modified: |
06 Mar 2024 00:15 |
Publisher DOI: |
10.1001/jama.2024.0589 |
PubMed ID: |
38324409 |
BORIS DOI: |
10.48350/192673 |
URI: |
https://boris.unibe.ch/id/eprint/192673 |